BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Roche (RHHBY) Picks NYC for New R&D Site


9/20/2012 8:21:16 AM

What New Jersey loses, New York City gains, at least in part. Roche, the Swiss pharmaceutical giant, will open a new research center in Manhattan that will take on some of the former responsibilities of its big campus in Nutley, N.J. Roche announced in June that it would shut the Nutley site, where the tranquilizer Valium was invented more than 50 years ago, as part of a cost-cutting effort that would eliminate about 1,000 jobs. At the time, the company said it would open a new translational clinical research center somewhere on the East Coast. The company is expected to formally announce Thursday that it will locate that new operation in the Alexandria Center for Life Science, at 29th Street and First Avenue in Manhattan.


Roche
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES